- Generic: hard pill to swallow
Innovative pharma companies are adopting increasingly aggressive strategies to prolong the life of their product patents and keep generic p...
- Sun Pharma eyes acquisition in US
Sun Pharmaceuticals has prepared a war chest of $500 million for acquisitions in the US, as it bets big on the world's largest drugs market.
- Sun Pharma has high stakes in patent war
If Sun Pharmaceutical succeeds in its challenge against Eli Lilly’s patent on cancer drug, it could reap a windfall.
- New drug dose helps local firms regain health in US
Domestic pharma majors are witnessing sharp recovery in their US business.
- Starry show among stars and stripes
In spite of steep pricing pressure and increasing competition, domestic pharma majors, including Ranbaxy Labs, Dr Reddy’s Labs, Cipla and S...